Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.

Journal of clinical pharmacy and therapeutics - 1 Aug 2018

Imatoh T, Sai K, Saito Y

Abstract excerpt

WHAT IS KNOWN AND OBJECTIVE: Clinically validated pharmacogenomic information useful for patient selection and/or dose adjustment is included in drug labels. However, the label information may differ among countries. This commentary summarizes the pharmacogenomic information on drug labels in different countries. COMMENT: We selected six drugs, namely, clopidogrel, atomoxetine, irinotecan, mercaptopurine,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug-Related Side Effects and Adverse Reactions
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Pharmaceutical Preparations

Share to Pharmacogenetics

Share to United States

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 29682780
DOI: 10.1111/jcpt.12691

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.PMID 29682780Read ↗

Dosing recommendations for pharmacogenetic interactions related to drug metabolism.Semantic proximity Read ↗

Recommendations for pharmacogenetic testing in clinical practice guidelines in the USSemantic proximity Read ↗

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx GuidelinesSemantic proximity Read ↗

Adding pharmacogenetics information to drug labels: lessons learned.Semantic proximity Read ↗

Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.Semantic proximity Read ↗

Cytochrome P450 genotype-guided drug therapies: An update on current states.Semantic proximity Read ↗

Pharmacogenomics in clinical practice and drug development.Semantic proximity Read ↗

[How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].Semantic proximity Read ↗

Practical Recommendations for Pharmacogenomics-based Prescription: 2010 ESF–UB Conference on Pharmacogenetics and PharmacogenomicsSemantic proximity Read ↗

Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.Semantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.